n-Cyclopentylcyclohexanamine → [5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	n-Cyclopentylcyclohexanamine	HCID 219797	—
Edukt	Ethyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]acetate	HCID 351912	—
Edukt	[5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid ethyl ester	HCID 66872747	—
Produkt	[5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid	HCID 57883528	—

Reaktionsschritte

[5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid ethyl ester prepared as described in general procedures (A) and (B) using cyclohexyl-cyclopentyl-amine and ethyl-2-[5-amino-1,3,4-thiadiazol-2-yl-thio]acetate. Hydrolysis using general procedure (F) gave the title compound.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US07851636B2
Quelldatensatz	uspto-grants-2010_12
ORD ID	ord-639dc4ac3b4e4ed0b008d3fc844a7b1e
Quellennotiz	uspto-grants-2010_12